755
www.praktickelekarenstvi.cz550715901901162343533734625085796456977297988639379691045111111831228130213851442149115661599162516941761
/559271590190101
Prakt.572871590190126169241306359386
lékáren.61497159019034110175248292366450476
2019;66607159019078153221285311
15(1e):70067159019078142179247313349372
e3–e1474137159019078153232313376442
/789071590190101
PRAKTICKÉ802671590190127207305385468506599678756
LÉKÁRENSTVÍ88197159019073149228330411488589663741833870
e1397617148020186169251
MEDICAMENTA78492940227156260392452563690848952108411881302
NOVA91912940227127261381497
BREXPIPRAZOL8985508018860122177243303331391451523582649703
LITERATURA552925020884132225317418533615733834949
1.550115601576686
Češková6591158015574133179232298354411
E.1094115801556082
Postavení11991158015565130176216273329389456481
aripiprazolu1703115801555995121190216285322380432498524590
v23171158015558
klinické2399115801555582107173198254307367
praxi.27891158015572108166222247268
Čes30811158015574133179
a32841158015559
slov3367115801554873140196
Psychiatrie35871158015565110167222289314370407444469530
2011;41411158015563123178225237
107:44011158015563118175190
110–114.46141158015564110165233286333387407
2.550131601576793
Mohr67213180155101170238275
P,975131801556670
Kopeček10741318015564131202265323383436
M,153913180155101123
Brunovský16911318015566103171239307363410463524
M,224413180155101123
et23961318015563101
al.2526131801555985106
Kariprazin26611318015565124160187256293352405431498
in3188131801552794
Klinická3311131801556593118185210267319379
psychofarmakologie.Maxdorf,37191318015572118176232299367400460496602659712779805873944969103110511153121012665501478015571139176213230
2017,8091478015563123179230236
pp10741478015572142
161–164.12451478015563118170228282336401422
3.550163601576792
Ceskova6661638015574134181233300356415
E,1105163801556182
Silhan1212163801556185110177234302
P.1539163801556570
Novel16341638015583151208268294
treatment1957163801553673134190227333394462499
options24811638015569140178204272340386
in2896163801552391
depression30111638015571133203240300348394419486555
and35911638015559126196
psychosis.38121638015571119176232300368414439484507
Neuropsychiatr43441638015583144212248314385432490545613638550179801555996133
Dis7121798015584110155
Treat896179801556089149205243
2018;11671798015564124180234253
14:14491798015563117137
741–747.16141798015564117170227283335392399
4.550195601576790
Citrome660195801557497133168231334394
L.1074195801555878
The11721958015560127187
ABC’s13791958015576137207224265
of16641958015569100
dopamine17841958015570136204260361384449508
receptor2318195801553390146203270305368403
partial27411958015572128162203225279302
agonists30631958015559126192258280323361407
-34951958015533
aripiprazole,3548195801555993117184207274309365415479503562579
brexpiprazole41461958015572107165218286309376411467516580604663
and48291958015559124192
cariprazine:5502118015558114147171238273328378402467526544
the11202118015537103162
15-min13052118015564113149253275340
challenge16682118015558123178201223283348415474
to21682118015538101
sort22922118015548114149189
these25072118015538103163207267
agents27972118015559126185251285331
out.31512118015569134171190
Int3367211801552590124
J35172118015542
Clin3583211801557496119183
Pract3790211801556598154208248
2015;40612118015563121174224238
69:43222118015564121140
1211–1220.44852118015564113165210265316365425482500
5.550227601576690
Maeda66422780155101158220290346
K,1034227801556589
Sugino11472278015560126195220287355
H,15262278015581102
Akazawa16522278015576129188240299389447
H,21232278015582102
et22492278015563101
al.2374227801555984105
Brexpiprazole25032278015565102162217287313382419477529595621683
I:3214227801552343
in3285227801552390
vitro3398227801555985124160226
and36482278015559126195
in3871227801552390
vivo3985227801555884142208
characterization42172278015558125182218276332374433470495546605642668735803
of5502438015568100
a6722438015558
novel7522438015568135189248273
serotonin-dopamine104724380155481081442082443083743984645015716387067638658899541015
activity20842438015558113154178234259296355
modulator.246124380155104171240304329384420484519534
J30222438015540
Pharmacol30842438015564128184219322377432496521
Exp36282438015559115184
Ther38342438015559127188223
2014;40792438015562121175227245
350:43462438015563119178198
589–604.45662438015562121180245310372435454
6.550259601576793
Mohr68125980155101170238275
P,984259801557478
Kopeček10912598015574140211274332391445
M,157325980155101124
Brunovský17252598015575112180248316373420472533
M,229525980155102124
et24482598015572110
al.2587259801556893114
Brexpiprazol,27302598015575111172227298324394431489542608635655
in34132598015536104
Klinická35452598015574102127194219276329388
psychofarmakologie.3961259801558112818624130937741046950561166872178881588395397810401060
Maxdorf,55027580155101159215283351388425442
2017,10202758015564124180231237
pp12862758015571142
135–138.14562758015564116174239292344405428
7.550291601576780
Stahl6602918015570107166235261
SM.9502918015571170194
Mechanism118329180155102165224292350419444491596
of18082918015580113
action19502918015570127170197266336
of23152918015579113
brexpiprazole:24572918015582120181238309336407445503556624651714734
comparison32202918015569135242313372409436482551621
with38792918015595122162231
aripiprazole.41392918015570107133204231301339398451518545608628
CNS47962918015585166225
Spectr5503078015560129193251293330
2016;9083078015564124180234254
21:1–6.11913078015563118130182240306328
8.550323601576794
Citrome6753238015574100138175242347409
L,1113323801556083
Ota12273238015587128187
A,1445323801557699
Nagamizu15753238015583140210267371397448516
K,2122323801556589
et22423238015563102
al.2372323801556287108
The25093238015563133195
effect2735323801556396132192250292
of30583238015569102
brexpiprazole31913238015572109170225296322392429487540606632694
(OPC-34712)39143238015537119184256277334397453510562593
and45353238015561129199
aripiprazole47623238015562981241942205503398015572109167220286313375
in953339801552895
adult10773398015559129195221260
patients13653398015572131169194256324360409
with18033398015594120159227
acute20593398015559115183222281
schizophrenia:23693398015549106173198250316386455491552619645701721
results3118339801553999146212238276325
from3472339801553472139244
a37453398015559
randomized,3832339801553998165235303408434485545616636
exploratory44973398015563119190216284322380417483550355801553899
study.678355801554888156226282297
Int1004355801552795132
Clin11643558015574100124192
Psychopharmacol13843558015566111169225292360431500557593699756813878905
2016;23183558015563123179234253
31:26003558015563117130
192–201.27583558015564116174235290351406420
9.550371601576786
Citrome668371801557497133167231333393
L.1087371801556485
Activating12043718015576128168191246301336359425492
and17213718015566131198
Sedating19453718015566126194249284307372439
Adverse24163718015576141197255289334393
Effects2835371801556797132189245284330
of31973718015570100
Second-Generation33233718015566126181244310377413495555620680714770805828892958
Antipsychotics43133718015576142176199266310365419484550585608661707
in550387801552792
the6683878015540106165
Treatment859387801556187144198233335395460495
of1380387801556999
Schizophrenia15053878015561115180203251315383449483541606628682
and22133878015559124191
Major243138780155101156179244278
Depressive27363878015584144211246304348392414469527
Disorder.32893878015584108151216251316375409423
Absolute37383878015576144188253278342378435
Risk4199387801556689132182
Increase4407387801552893147181239292336396
and48293878015559124191
Number5504038015583148249317377411
Needed9854038015583142203271330398
to14094038015538101
Harm.15334038015582136170273293
J18514038015543
Clin1917403801557497119184
Psychopharmacol21244038015565108163216281347415481536569673727781844868
2017;30164038015563121174222234
37:32744038015563117130
138–147.34274038015563113171234286337391396
10.5504196015767123146
Stoner7214198015566100163229288322
SC.10694198015566136155
Management125541980155102157222276343402505564629664
of19504198015569100
serious20764198015554113147171236301344
cardiac24464198015564119153218241295349
adverse28214198015564132187245279324384
effects3236419801556394129187243282328
of3596419801556999
antipsychotic37214198015564130164187255299354407472538573596650
medications.440241980155106166234257311367401424489555598618
Ment55043580155101161226260
Health8344358015582141195218254319
Clin1177435801557496119183
2017;13844358015563121174222234
7:1642435801556376
246–254.17414358015564117179244297356416434
11.5504516015767119138
Polcwiartek7164518015570135162219314340397433476536589
C,1338451801557496
Sneider14624518015565132194219289351387
B,1878451801557090
Graff20014518015582119177211246
C,2280451801557495
et24044518015567106
al.2538451801556490111
The26774518015565135197
cardiac29024518015563121157225250307364
safety32944518015553112145206244304
of36314518015569102
aripiprazole37624518015563100126196222291328387440506533595
treatment4385451801554582142198236341403471508
in4921451801553299
patients5504678015572131168194255323360408
at987467801556299
high1118467801556994164231
risk1378467801554167113165
for15724678015537104141
torsade:17414678015543109146194253323384405
a21744678015562
systematic22654678015551108156196255360417455480537
review28304678015541102159185247339
with32004678015594120159227
a34554678015562
meta-analytic354946780155106169207265304361429486512568611637693
approach.42714678015562131202239306365421489511
Psychopharmacology481346780155651111695504838015558126194265333390427532590646712739807877934
(Berl)1513483801553498160197223256
2015;17984838015563124179232248
232:20754838015563125182202
3297–3308.23064838015563121181239296352411472535557
12.5504996015767123149
Chattopadhyay7264998015574141199236279344415474543611665724778
A,15314998015576100
Frey1658499801556094154209
S,Green1895499801556081159197257320388
G.23104998015581104
Bifeprunox2442499801556591124185255292360428496549
versus30194998015559119156203270315
placebo3362499801557298155212272341411
for38014998015533100137
schizophrenia.39674998015547104171197248314385453490550618643699721
Cochrane47154998015574140198266550515901553897165227
Database8065159015584141178236306365411473
Syst13085159015560112160200
Rev15365159015566128185
2016;17495159015564124180234254
10:20315159015564119140
CD012029.22005159015574155219275327387445505522
13.5505316015767122145
Maeda72353190155101157218287343
K,1093531901556589
Lerdrup12095319015558117152219254321389
L,1625531901555980
Sugino17325319015560126194218284351
H,21105319015582102
et22395319015563100
al.2366531901555984103
Brexpiprazole24975319015565101160214283308376412470521586611671
II:319653190155275170
antipsychotic-like32935319015559126161186254299356410476543580604659689715739790849
and41695319015559126194
procognitive43905319015572108173229294363429453491515571631
effects550547901556395131190247288335
of9145479015569101
a10445479015559
novel11325479015570137192251276
serotonin-dopamine143554790155511121472122483123804034705075786457147728758999651025
activity24905479015559114155179236261298357
modulator.287654790155107174243309333388425489525539
J34435479015546
Pharmacol35185479015566131187222326382438502527
Exp40745479015561117187
Ther42905479015560129190225
2014;45445479015563122177230247
350:48205479015564121180200
605–614.5505639015563125184248313365417437
14.5505796015767124150
Rexulti7245798015566128183251276315340
(brexpiprazole)10925798015531101138198254324350420457516568634661722751
[product18725798015530101138204274341398440
information].2340579801552390122189226332389426452519587616635
Tokyo,29995798015561120174234301320
Japan:3348579801554097167225293312
Otsuka36845798015587128177243296355
Pharmaceutical40635798015565131188224330387444503570609634691749774
Co,48615798015574140159
Ltd550595801555895162
2015.7415958015563124179231251
15.5506116015766119141
I.717611801552140
OPDC:7776118015586147224295314
PET11116118015564118178
Trial1309611801555985109162185
to15146118015539102
Assess16366118015574120164223267310
the19666118015540104164
Receptor21496118015565124179235302337400434
Occupancy26036118015586141192256323379443497554
of3176611801556899
Brexpiprazole3295611801556498156208276299366400456505568593651
in3972611801552185
Adult40776118015574139203226262
Subjects43596118015559122189212271326365411
With479061180155105129165230
Schizophrenia.5506278015560115181204253317386453487545611634689709
[cited1286627801552879102139197265
201815726278015563121175227
Nov18206278015582149203
11].20446278015563108132149
Available22146278015576127184207231285353378438
from:2679627801552864128231249
http://clinicaltrials.gov/show/NCT0185494429496278015569104145213231277309357381404469493547603627664699724778802845866933999105410921132119712631353139214731544160616641718177018281889194520072071
16.5506436015767126152
Correll7326438015574140177215275301326
CU,10886438015574153170
Skuban12876438015562114182252310378
A,16956438015576100
Ouyang18256438015587156213271339408
J,2262643801554666
et23586438015563101
al.2488643801556186107
Efficacy2626643801556090123156213271328388
and30436438015560128198
Safety32716438015560118151212250310
of36126438015569102
Brexpiprazole37446438015566102163218289315385422480533599626687
for44606438015536103140
the46286438015542110172
Treatment4830643801556189150550659801555996201263330367
of9416598015569102
Acute10676598015576131198237296
Schizophrenia:13876598015560117184209260326397465501561629653710729
A21406598015576
6-Week22406598015563104208266329382
Randomized,26466598015566124191260328433458509569640660
Double-Blind,33306598015584153221290317378418484510535602671692
Placebo-Controlled4046659801556589146202262331400441518583651688725791817842904974
Trial.5220115801556089115171197218
Am54671158015576181
J56761158015545
Psychiatry57491158015566111169224292317374411448509
2015;62861158015564124180232248
172:65631158015563114175195
870–880.67871158015563121180248312376439459
17.52201316015767122134
Kane53851318015565125192254
JM,56681318015546146168
Skuban58661318015560113181251309377
A,62731318015576100
Ouyang64031318015587156213271339409
J,6840131801554766
et69361318015563102
al.7066131801556187108
A72041318015576
multicenter,731013180155107174199238263320379447484544580595
randomized,7934131801554099166236304409434486546616637
double-blind,86011318015571139207277303365406477504529596666686
controlled931613180155601251942312673345220147801552853114185
phase54361478015572140197244306
357731478015563
trial5865147801554279105161187
of60831478015569102
fixed-dose6216147801553163117177248287359427474536
brexpiprazole67831478015572109169225295321391428487539605632694
for75051478015537104141
the76741478015543111173
treatment7875147801554380140196234339401469506
of84111478015570103
adults85421478015561131198223262311
with88831478015594120159227
acute91381478015562119186225285
schizophrenia.9451147801555110817520052201638015552119189258294354422447504526
Schizophr57741638015561118185210262328398467503
Res63061638015565128175
2015;65091638015564124180232248
164:67861638015563118183203
127–135.70171638015563115173230284336394413
18.52201796015767125152
Ishigooka5400179801553076143168237306375429488
J,5917179801554766
Iwashita60121798015530122180226293318357415
S,Tadori6456179801556283136184254322360386
Y.6873179801556578
Efficacy6979179801556393126159216274331391
and73981798015562129199
safety76261798015550109142203241301
of79581798015569102
brexpiprazole80911798015572109170225296322392429487540606633694
for88141798015536103141
the89831798015543111173
treatment9184179801554380140196234339401469506
of52201958015569102
acute53461958015559116183222281
schizophrenia56511958015548105173198249315385454490550618643699
in6378195801552390
Japan:6497195801554097166225293312
A68331958015576
6-week,69331958015563104197258321374399
randomized,7360195801553493160230298403428479539609630
double-blind,80141958015571138206276302364404476502527594664684
placebo-controlled8722195801557299155212271341410451511576645681718784811836898968
study.5220211801554889156226282298
Psychiatry55462118015565111169224292317373411448509
Clin6083211801557499124192
Neurosci63032118015583145213249315362419444
2018;67752118015564124180234254
72:70572118015564124145
692–700.72302118015564124182243298356421441
19.52202276015767123143
Kishi5394227801556591135201225
T,5646227801556476
Oya57532278015587144201
K,5985227801556488
Matsui610422780155101157193240305329
Y,6464227801556576
et65702278015563101
al.6698227801556287107
Comparison68352278015574139243311368404428473539607
of74722278015570101
the76002278015544111172
efficacy7802227801556394127160215272327386
and82152278015562129197
safety84392278015552110141201238297
of87672278015569100
488982278015564
and89892278015562129197
2mg/day92172278015563190258303364420473
brexpiprazole52202438015571107165218287311378414470520585609669
for5916243801552892128
acute60642438015559114179216274
schizophrenia:63582438015548103169192241305374440475533599622676694
a70732438015558
meta-analysis715224380155106166203259296351416471495549594617661
of78332438015569100
double-blind,79542438015570136202269294354392462487510575643661
randomized8642243801553289155222288391414463522590
placebo-9253243801557196151206263331398437
-controlled5220259801553997162229264300365390414475544
trials.5791259801553975100155179223244
Neuropsychiatr60612598015583144210245310379425481535601625680716752
Dis68392598015584109153
Treat7018259801556087146201237
2018;72812598015564123177230248
14:75552598015564117135
2519–2530.77162598015563124177228294348408465525544
20.52202756015767129153
Fleischhacker5399275801556083143167212267334400456511563622657
WW,608327580155106215229
Hobart63382758015582149218275310352
M,671627580155101123
Ouyang68652758015587155210267333402
J,7294275801554462
et73822758015563100
al.7508275801555984103
Efficacy7638275801556089122155210267322381
and80452758015559125193
Safety82652758015560117148208245304
of85952758015569100
Brexpiprazole87222758015565101160214283308376412470521586611671
(OPC34712)9421275801553311517824952202918015563125179234284313
as55532918015559104
Maintenance567829180155100156179245280338403459524579637
Treatment6336291801556087145199235338398464499
in6862291801552187
Adults69692918015576142207231268314
with73042918015594118155221
Schizophrenia:75462918015560115181204254318387453488546612635690708
a82752918015559
Randomized,83542918015566122188255321425448497556624643
Double-Blind,90182918015584151217285310370408472497520585653672
Placebo-Controlled5220307801556588144199258326394434510574641677713778803827887957
Study.6203307801556095161229285299
Int6529307801552692128
J66843078015544
Neuropsychopharmacol6754307801558214420924430937942448053460166873780486089510001056111111751201
2017;79813078015563122177226239
20:82463078015564123143
11–21.84153078015563109166220274286
21.52203236015767127148
Thase53973238015563134192240304
ME,573332380155101161184
Youakim59493238015565126195254308337442
JM,64213238015547147171
Skuban66223238015562116185257316385
A,70393238015576101
et71703238015565105
al.7304323801556188111
Efficacy7445323801556294127160218277336397
and78713238015561130201
safety81023238015551111144207246308
of84423238015569103
adjunctive85753238015561132159227296354397425484546
brexpiprazole9152323801557211117222930132940043849852203398015552120148211
254593398015564
mg554833980155106177
in5755339801552594
major587733980155107165192261300
depressive62053398015570134205244305353401427486548
disorder:6781339801557197144213252321384422446
a72553398015559
phase73423398015572142201248312
3,7682339801556384
randomized,7796339801553697165236306412439491553625647
placebo-controlled84713398015572100158216277348419461522589659697735803831857920992
study949333980155478815752203558015571129
in53783558015535103
patients55113558015579139177204267336374424
with59723558015594122162231
inadequate62333558015534103161232295367435494533593
response68563558015546107156226297367414477
to73633558015547114
antidepressants.75073558015566135173200271334405444505554601662730769819843
J83793558015552
Clin84683558015574101127196
Psychiatry86933558015573120179236305331389427466528
2015;92503558015571133190243261
76:95413558015570128149
1224–1231.52203718015563117180237305360413476531547
22.52203876015767132158
Thase54063878015564134191237300
ME,573838780155101160181
Youakim59513878015566125193250303331435
JM,64143878015549148170
Skuban66123878015564117185255313381
A,7025387801557699
et71533878015566105
al.7286387801556388109
Adjunctive74273878015576145170237305361404429487547
brexpiprazole80063878015572109170225296322392429487540606633694
187293878015567
and88243878015563130200
390533878015567
mg914238780155107176
for93473878015537104142
patients952138780155711305220403801554066128196233281
with55334038015594120159227
major579240380155107164190258295
depressive61194038015570132202239300347393418475536
disorder6687403801557196141209246314376413
following71284038015538105131156224316342410479
inadequate7636403801553198155224286357424481518578
response82424038015542102149219288357402464
to87354038015543109
antidepressants:88724038015563131168194263325395432492539586644712749798818
a52204198015559
phase53074198015572141198244306
3,5642419801556383
randomized,5753419801553998165235303408433485545616636
double-blind64184198015570138206276303365405477503528596665
study.7112419801554888156226282298
J74384198015545
Clin75114198015574100124192
Psychiatry77314198015566111169225292317374411448509
2015;82684198015564124180232249
76:85454198015563119140
1232–1240.87134198015563115177234295349400456520541
23.52204356015767132157
Hobart54104358015582150221280316359
M,580343580155101123
Skuban59554358015565118186255314382
A,6370435801557699
Zhang65034358015570137194262332
P,6863435801557074
et69664358015567106
al.7100435801556490111
A72444358015576
Randomized,73494358015570128196266334439464515576646667
Placebo-Controlled8044435801557095152208268338407448525591659696733800826851913984
Study90564358015565101169239295
of93844358015570103
the95154358015545113175
Efficacy5220451801556191124157214272329388
and56364518015559126196
Safety58594518015560119151212250311
of61974518015569102
Fixed-Dose6326451801556085140200270309393462509571
Brexpiprazole69244518015566103163219289315385422481533599626688
276394518015563
mg/d772545180155106176222285
as80374518015559105
Adjunctive81694518015576145170237305361404429487547
Treatment8744451801556088149205242347410477514
of92854518015570103
Adults941545180155761442112365220467801554089
With533746780155107134173241
Major560646780155101159185252289
Depressive59244678015584147217254315362408433490551
Disorder.65034678015584110156224261329391428444
J69754678015545
Clin70484678015574100125192
Psychiatry72684678015566111169225292317374411448509
2018;78054678015564124180234253
79.80874678015563122140
24.52204836015767128154
Bauer54034838015566125191253290
M,572248380155101123
Hefting58744838015582144177221246314383
N,62864838015583104
Lindsten6418483801555984152222267307367435
A,6882483801557699
et70104838015563101
al:7140483801555985104
A72734838015576
randomised,7377483801553998165235303408434479541612633
placebo-controlled8038483801557299155212272342411452512577646683720786813838900970
24-week90374838015563119159253314377431
study949648380155498915652204998015571127
evaluating53754998015572129187213279337374400467537
adjunctive59404998015568137163230297354396422480541
brexpiprazole65094998015580117178233304330400437495547613639701
in72394998015535103
patients73704998015580138176202264331368417
with78244998015594120159227
major808849980155107164190258295
depressive84114998015579141211248309356402427485545
disorder.89854998015579104149217255322384421437
Acta94594998015576131173231
Neuropsychiatr52205159015583145212249315386432490545613638694732769
2018;60175159015564124180234253
1–9.62995159015564121183200
25.52205316015767132156
Lepola54045319015558119189258284341
U,5773531901558299
Hefting59005319015582144176221246313383
N,63115319015583104
Zhang64435319015570137194262332
D,68035319015584101
et69325319015563101
al.7061531901555985106
Adjunctive71955319015576144170237304361403429487547
brexpiprazole77705319015572109169225296322391429487539606632694
for84925319015534101138
elderly8658531901556389159221257284340
patients90265319015571130168193255323360408
with94625319015594120159227
major522054780155106163189257294
depressive55385478015571132202239300346393417475535
disorder:6098547801557095141209246314376412435
An65575478015576144
open-label,67255478015569140203271310337394464527553573
long-term7326547801552391160229268307366402508
safety78585478015549108140201239299
and81815478015559127196
tolerability84065478015536101128189226285355381406431469529
study.8959547801554989156226282298
Int9285547801552391128
J94415478015540
Geriatr950654780155811445220563801553865121158195
Psychiatry54445638015565111168224292317373410447508
2018;59815638015563123179233253
33:62625638015564122140
1403–1410.64305638015564118182240305359413466521541
26.52205796015766128153
Otsuka53965798015586126174239291349
Pharmaceutical57675798015565130186221325381437495561599624679736761
Development65515798015583145201260285352421525586652688
&72615798015572
Commercialization73545798015573138241344405441494518574598622672731767792858925
I.8307579801552244
A83735798015576
study8471579801554887154222277
of87715798015569101
two88995798015535130195
fixed-doses9117579801553162116175244282353420466526572
of52205958015569102
brexpiprazole53525958015572109170226296322392429487540606633695
in6075595801552996
the62005958015542110172
treatment6401595801554279139195232337400468505
of69365958015569102
subjects70665958015551117187213274332374423
with75195958015594120159227
agitation77745958015561131156195253290316384452
associated82555958015561107153222279305361398458529
with88145958015594120159227
dementia90715958015571133237300368405430487
of95885958015569102
the52206118015540108170
Alzheimer’s54176118015577102153222284309414476512537580
type6025611801553999171234
[Internet]6287611801553360127164224260329391430459
Bethesda67736118015566129167236298345414472
(MD):72736118015533130213242262
National75626118015583140177203270339396422
Library8011611801555884154191249286346
of83856118015569102
Medicine851461180155101163234259316341408470
(US);90136118015533112168200219
200092596118015564124188253
[cited954061180155348611152206278015540100170
201854196278015563124179233
Nov56816278015583151208
11].59176278015564111136155
Available61016278015576130188213238295365392454
from:6583627801553472138244263
http://clinicaltrials.gov/show/NCT01862640;6875627801556910614921923928732137139642148951457062865469373075681283888390697510431099113911811249131714091450153216061669173017851840190319622021208621512172
27.52206436015767129141
Rexulti,53896438015573135191259284323348369
brexpiprazole57936438015572109169225295321391428487539605632694
(summary6515643801554286152257361418455515
of70596438015576109
product72036438015572109175246313370412
characteristics).76436438015565133190226284341384443480506551592617674722751768
the84396438015547115177
European86456438015567132168235305368424492
Medicines917264380155102164235260316341409471518
Agency52206598015576144206274331391
http://www.ema.europa.eu.5639659801557010714921923928732141351060662368478984686893099710341100117012291251131313801402
2018.70696598015563124179234256